- Home
- FLC vs CBUS Comparison
FLC vs CBUS Comparison
Compare FLC & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLC
- CBUS
- Stock Information
- Founded
- FLC 2003
- CBUS 2010
- Country
- FLC United States
- CBUS United States
- Employees
- FLC N/A
- CBUS N/A
- Industry
- FLC Trusts Except Educational Religious and Charitable
- CBUS Agricultural Chemicals
- Sector
- FLC Finance
- CBUS Industrials
- Exchange
- FLC Nasdaq
- CBUS Nasdaq
- Market Cap
- FLC 168.0M
- CBUS 160.8M
- IPO Year
- FLC N/A
- CBUS 2017
- Fundamental
- Price
- FLC $17.11
- CBUS $5.15
- Analyst Decision
- FLC
- CBUS Strong Buy
- Analyst Count
- FLC 0
- CBUS 3
- Target Price
- FLC N/A
- CBUS $23.67
- AVG Volume (30 Days)
- FLC 37.8K
- CBUS 141.3K
- Earning Date
- FLC 01-01-0001
- CBUS 11-07-2024
- Dividend Yield
- FLC 6.64%
- CBUS N/A
- EPS Growth
- FLC N/A
- CBUS N/A
- EPS
- FLC N/A
- CBUS N/A
- Revenue
- FLC N/A
- CBUS $2,961,000.00
- Revenue This Year
- FLC N/A
- CBUS $36.93
- Revenue Next Year
- FLC N/A
- CBUS $236.45
- P/E Ratio
- FLC N/A
- CBUS N/A
- Revenue Growth
- FLC N/A
- CBUS 816.72
- 52 Week Low
- FLC $12.62
- CBUS $4.26
- 52 Week High
- FLC $15.45
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- FLC 75.89
- CBUS 38.41
- Support Level
- FLC $16.79
- CBUS $4.77
- Resistance Level
- FLC $16.96
- CBUS $7.49
- Average True Range (ATR)
- FLC 0.12
- CBUS 0.63
- MACD
- FLC 0.00
- CBUS 0.02
- Stochastic Oscillator
- FLC 100.00
- CBUS 37.15
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.